TRK-950

· Toray Industries, Inc

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TRK-950, covering 2025-04-16 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TRK-950 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]